Tempest Therapeutics, Inc. Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs
Tempest Therapeutics, Inc. (TPST) reported Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs of $2.25 million for the 6-month period ending 2012-06-30, per its 10-Q filed 2012-08-14.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts · last filed 2012-08-14
- Tempest Therapeutics, Inc. adjustments to additional paid in capital, stock issued, issuance costs for the quarter ending 2011-06-30 was $101.00K.
| Period end | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs 3 month | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs 6 month |
|---|---|---|
| 2012-06-30 | $2.25M 10-Q · filed 2012-08-14 | |
| 2011-06-30 | $101.00K 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |